593 related articles for article (PubMed ID: 27174990)
1. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.
Lu C; Jain SU; Hoelper D; Bechet D; Molden RC; Ran L; Murphy D; Venneti S; Hameed M; Pawel BR; Wunder JS; Dickson BC; Lundgren SM; Jani KS; De Jay N; Papillon-Cavanagh S; Andrulis IL; Sawyer SL; Grynspan D; Turcotte RE; Nadaf J; Fahiminiyah S; Muir TW; Majewski J; Thompson CB; Chi P; Garcia BA; Allis CD; Jabado N; Lewis PW
Science; 2016 May; 352(6287):844-9. PubMed ID: 27174990
[TBL] [Abstract][Full Text] [Related]
2. The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas.
Fang D; Gan H; Lee JH; Han J; Wang Z; Riester SM; Jin L; Chen J; Zhou H; Wang J; Zhang H; Yang N; Bradley EW; Ho TH; Rubin BP; Bridge JA; Thibodeau SN; Ordog T; Chen Y; van Wijnen AJ; Oliveira AM; Xu RM; Westendorf JJ; Zhang Z
Science; 2016 Jun; 352(6291):1344-8. PubMed ID: 27229140
[TBL] [Abstract][Full Text] [Related]
3. Histone Lysine-to-Methionine Mutation as Anticancer Drug Target.
Yang J; Qiu Q; Chen L
Adv Exp Med Biol; 2021; 1283():85-96. PubMed ID: 33155140
[TBL] [Abstract][Full Text] [Related]
4. Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression.
Jain SU; Khazaei S; Marchione DM; Lundgren SM; Wang X; Weinberg DN; Deshmukh S; Juretic N; Lu C; Allis CD; Garcia BA; Jabado N; Lewis PW
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27354-27364. PubMed ID: 33067396
[TBL] [Abstract][Full Text] [Related]
5. Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.
Rajagopalan KN; Chen X; Weinberg DN; Chen H; Majewski J; Allis CD; Lu C
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619101
[TBL] [Abstract][Full Text] [Related]
6. Histone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis.
Shi L; Shi J; Shi X; Li W; Wen H
J Mol Biol; 2018 May; 430(11):1562-1565. PubMed ID: 29689253
[TBL] [Abstract][Full Text] [Related]
7. H3.3 K36M Mutation as a Clinical Diagnosis Method of Suspected Chondroblastoma Cases.
Mu H; Jiang Y; Xue L; Hua Y; Lin J; Cai Z
Orthop Surg; 2021 Apr; 13(2):616-622. PubMed ID: 33620145
[TBL] [Abstract][Full Text] [Related]
8. Probe the function of histone lysine 36 methylation using histone H3 lysine 36 to methionine mutant transgene in mammalian cells.
Fang D; Gan H; Wang H; Zhou H; Zhang Z
Cell Cycle; 2017 Oct; 16(19):1781-1789. PubMed ID: 28129023
[TBL] [Abstract][Full Text] [Related]
9. Histone Lysine-to-Methionine Mutations Reduce Histone Methylation and Cause Developmental Pleiotropy.
Sanders D; Qian S; Fieweger R; Lu L; Dowell JA; Denu JM; Zhong X
Plant Physiol; 2017 Apr; 173(4):2243-2252. PubMed ID: 28202597
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase.
Yang S; Zheng X; Lu C; Li GM; Allis CD; Li H
Genes Dev; 2016 Jul; 30(14):1611-6. PubMed ID: 27474439
[TBL] [Abstract][Full Text] [Related]
11. The incorporation loci of H3.3K36M determine its preferential prevalence in chondroblastomas.
Zhang Y; Fang D
Cell Death Dis; 2021 Mar; 12(4):311. PubMed ID: 33762579
[TBL] [Abstract][Full Text] [Related]
12. Histone H3K36M mutation and trimethylation patterns in chondroblastoma.
Lu C; Ramirez D; Hwang S; Jungbluth A; Frosina D; Ntiamoah P; Healey J; Zhu G; Chen W; Klein M; Hameed M
Histopathology; 2019 Jan; 74(2):291-299. PubMed ID: 30098026
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for the role of oncogenic histone mutations in modulating H3K36 methylation.
Zhang Y; Shan CM; Wang J; Bao K; Tong L; Jia S
Sci Rep; 2017 Mar; 7():43906. PubMed ID: 28256625
[TBL] [Abstract][Full Text] [Related]
14. H3K36 methylation antagonizes PRC2-mediated H3K27 methylation.
Yuan W; Xu M; Huang C; Liu N; Chen S; Zhu B
J Biol Chem; 2011 Mar; 286(10):7983-7989. PubMed ID: 21239496
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.
Lewis PW; Müller MM; Koletsky MS; Cordero F; Lin S; Banaszynski LA; Garcia BA; Muir TW; Becher OJ; Allis CD
Science; 2013 May; 340(6134):857-61. PubMed ID: 23539183
[TBL] [Abstract][Full Text] [Related]
16. Histone Mutations and Bone Cancers.
Taylor EL; Westendorf JJ
Adv Exp Med Biol; 2021; 1283():53-62. PubMed ID: 33155137
[TBL] [Abstract][Full Text] [Related]
17. S-adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3.
Jayaram H; Hoelper D; Jain SU; Cantone N; Lundgren SM; Poy F; Allis CD; Cummings R; Bellon S; Lewis PW
Proc Natl Acad Sci U S A; 2016 May; 113(22):6182-7. PubMed ID: 27185940
[TBL] [Abstract][Full Text] [Related]
18. Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3-MutSα interaction.
Fang J; Huang Y; Mao G; Yang S; Rennert G; Gu L; Li H; Li GM
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9598-9603. PubMed ID: 30181289
[TBL] [Abstract][Full Text] [Related]
19. Recognition of cancer mutations in histone H3K36 by epigenetic writers and readers.
Klein BJ; Krajewski K; Restrepo S; Lewis PW; Strahl BD; Kutateladze TG
Epigenetics; 2018; 13(7):683-692. PubMed ID: 30045670
[TBL] [Abstract][Full Text] [Related]
20. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
